Dingjie Zhou

Medicine · Health Sciences

5h-index75citations14works4.72yr avg
OpenAlex↗ORCID↗Google Scholar↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Cancer Immunotherapy and Biomarkers(8), Lung Cancer Research Studies(7), Lung Cancer Treatments and Mutations(5), Hepatocellular Carcinoma Treatment and Prognosis(3), Inflammatory Biomarkers in Disease Prognosis(3)

Publications14 total

Spatiotemporal imbalance of regional water shortage risk based on copulas and concentration index
Scientific Reports·2026Open Access
Inflammatory factors are associated with prognosis of non-small cell lung cancer patients receiving immunotherapy: a meta-analysis
Scientific Reports·2024· 11 citedOpen Access
The Association Between Modified Albumin-Bilirubin (mALBI) and Survival in Advanced Non-small Cell Lung Cancer Patients Treated With Immunotherapy
Cureus·2024· 3 citedOpen Access
Effects of LINC00261 targeting miR-148a/WNT10b axis on the proliferation and apoptosis of colorectal cancer cells
Heliyon·2023· 4 citedOpen Access
Baseline Albumin-Bilirubin grade as a predictor of response and outcome of regorafenib therapy in patients with hepatocellular carcinoma: a systematic review and meta-analysis
BMC Cancer·2023· 10 citedOpen Access
The safety and efficacy of immunotherapy and palliative radiotherapy in patients with metastatic non-small cell lung cancer: a systematic review and meta-analysis of 13 prospective studies
Expert Review of Anticancer Therapy·2023· 2 citedOpen Access
Assessing Potential Factors Influencing the Efficacy of Immune Checkpoint Inhibitors with Radiation in Advanced Non-Small-Cell Lung Cancer Patients: A Systematic Review and Meta-Analysis
Journal of Oncology·2023· 1 citedOpen Access
Assessing the Relationship Between Liver Metastases and the Survival of Patients With Non-Small Cell Lung Cancer After Immune Checkpoint Inhibitors Treatment: A Systematic Review and Meta-Analysis
Integrative Cancer Therapies·2023· 9 citedOpen Access
The safety and efficacy of immunotherapy and palliative radiotherapy in patients with metastatic non-small cell lung cancer: a systematic review and meta-analysis of 13 prospective studies
Figshare·2023Open Access
Baseline Albumin-Bilirubin grade as a predictor of response and outcome of regorafenib therapy in patients with hepatocellular carcinoma: a systematic review and meta-analysis
Annals of Translational Medicine·2023Open Access
The prognostic role of neutrophil-to-lymphocyte ratio and C-reactive protein in metastatic colorectal cancer using regorafenib: a systematic review and meta-analysis
Journal of Gastrointestinal Oncology·2022· 25 citedOpen Access
The efficacy and safety of immunotherapy and palliative radiotherapy in metastatic non-small cell lung cancer patients: a systematic review and meta-analysis
Research Square (Research Square)·2022Open Access
Effects of Linc00261 Targeting Mir-148a/Wnt10b Axis on the Proliferation and Apoptosis of Colorectal Cancer Cells
SSRN Electronic Journal·2022Open Access
Potential predictors for survival in hepatocellular carcinoma patients treated with immune checkpoint inhibitors: A meta-analysis
International Immunopharmacology·2021· 10 cited

Frequent Co-authors

Dedong Cao(13), Huilin Xu(9), Nan Zhao(5), Ximing Xu(4), Pingpo Ming(4), Wei Ge(3), Wei Ge(3), Xixian Tang(3), Yongfa Zheng(3), Zhenmin Jiang(3), Nan Zhao(2), Vishal G. Shelat(2), Hrishikesh Samant(2), Sanjaya K. Satapathy(2), Francisco Tustumi(2), Giuseppe Aprile(2), Anbing He(2), Juanli Xi(2), Huilin Xu(1), Ximing Xu(1)